J. Michael Pearson

2012 - Valeant Pharmaceuticals International

In 2012, J. Michael Pearson earned a total compensation of $6.1M as Chief Executive Officer at Valeant Pharmaceuticals International, a 83% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$3,827,056
Salary$1,712,500
Other$573,419
Total$6,112,975

Pearson received $3.8M in non-equity incentive plan, accounting for 63% of the total pay in 2012.

Pearson also received $1.7M in salary and $573.4K in other compensation.

Rankings

In 2012, J. Michael Pearson's compensation ranked 931st out of 11,487 executives tracked by ExecPay. In other words, Pearson earned more than 91.9% of executives.

ClassificationRankingPercentile
All
931
out of 11,487
92nd
Division
Manufacturing
341
out of 4,245
92nd
Major group
Chemicals And Allied Products
77
out of 1,183
94th
Industry group
Drugs
42
out of 905
95th
Industry
Pharmaceutical Preparations
38
out of 684
94th
Source: SEC filing on April 9, 2015.

Pearson's colleagues

We found three more compensation records of executives who worked with J. Michael Pearson at Valeant Pharmaceuticals International in 2012.

2012

Howard Schiller

Valeant Pharmaceuticals International

Chief Financial Officer

2012

Pavel Mirovsky

Valeant Pharmaceuticals International

President and General Manager, Europe

2012

Robert Chai-Onn

Valeant Pharmaceuticals International

Chief Legal Officer

You may also like